Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 June 2015 09:32
Scientists have hailed the potential of the new drug
A new drug could help patients with a devastating form of lung cancer to live longer, it has been suggested.
Nivolumab, an immuno-therapy drug that unshackles the immune system so it can attack cancerous cells, has been shown to double the life expectancy of genetically targeted patients with advanced non-squamous non-small cell lung cancer.
One expert has described the results of the major international trial as a "paradigm shift" in the battle against lung cancer.
Lung cancer is one of the UK's most serious forms of the disease.
Advanced non-squamous non-small cell lung cancer accounts for around 85% of all cases of the lung disease, which is diagnosed in 43,463 new patients and is responsible for 35,371 deaths each year in the UK.
Like other cancers, treatment depends on how far it has spread and how good your general health is.
But whether you are a cancer survivor or are undergoing treatment, cancer travel insurance means you can still enjoy jetting off to sunnier climes around the world with family and friends.
Policies can include cover for replacing lost medication and access to 24/7 emergency assistance.
Longer life expectancy
The new research, led by Dr Luis Paz-Ares, from the Hospital Universitario Virgen Del Rocio in Spain, compared the effectiveness of nivolumab and the standard chemotherapy drug docetaxel in 582 patients with advanced non-squamous non-small cell lung cancer.
Nivolumab reduced the risk of dying by 27% compared with docetaxel and increased typical survival time from 9.4 to 12.2 months.
In patients whose cancers produced higher levels of a tumour protein called PD-L1, survival time more than doubled from eight to 19.4 months.
Dr David Chao, consultant medical oncologist at the Royal Free Hospital in London, described the findings as a paradigm shift in the treatment of lung cancer.
01 December 2016
Pilots at German airline Lufthansa are on strike again after a two-day break in their campaign of walkouts.
02 December 2016
Britons are among the top spenders in Europe when it comes to holidays, new research has found.
30 November 2016
The UK should think about resuming flights to the popular tourism resort of Sharm el-Sheikh, according to a major United Nations agency.
29 November 2016
Plans are in place to develop a new aviation arrangement between the UK and US, to ensure holidaymakers can still fly between the two countries once Britain departs the EU.
26 November 2016
Hundreds of Lufthansa flights have been grounded after pilots working for the airline took part in a strike.
25 November 2016
The US is warning its citizens that Europe is facing a "heightened risk of terror attacks" at Christmas markets and other seasonal holiday events.
24 November 2016
A groundbreaking radiotherapy machine that can track the changing position of tumours in real time will soon be used to treat cancer patients in the UK.
23 November 2016
Top airline bosses are urging the government to scrap air passenger duty ahead of Wednesday's Autumn Statement.
22 November 2016
Winter sun is now the most popular holiday type, according to new research conducted by travel experts.
19 November 2016
A holiday price increase of 10% on trips to Europe could cause tourists to postpone their getaways next year, experts are warning.
18 November 2016
British citizens will no longer be able to travel freely to Europe without paying a "travel tax" or filling in visa forms under plans unveiled by Brussels.
17 November 2016
London mayor Sadiq Khan has signalled his support for a legal challenge to the expansion of Heathrow airport.